In the present study, the expression level of ATF6 in the AME group was significantly higher than that in the control group, and, with increasing periods of morphine exposure, the expression level of ATF6 increased in the initial stages of MD, and then decreased at 6 weeks. Here, ATF6 is linked to Menkes disease.